HSD24 Patient Characteristics Associated with the Use of Newly Approved Disease-Modifying Therapy (DMT) for Sickle Cell Disease in Texas Medicaid
Abstract
Authors
Yahan Zhang Hyeun Ah KANG Kristin M. Richards Alicia Chang Kenneth A. Lawson Mark Myers Udden